Page last updated: 2024-12-10

tamoxifen aziridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tamoxifen aziridine: estrogen receptor inactivator; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3033894
CHEMBL ID168622
MeSH IDM0099815

Synonyms (6)

Synonym
tamoxifen aziridine
1-[2-[4-[(z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl]aziridine
CHEMBL168622
aziridine, 1-(2-(4-(1,2-diphenyl-1-butenyl)phenoxy)ethyl)-, (z)-
79642-44-7
DTXSID501315605

Research Excerpts

Overview

Tamoxifen Aziridine ([3H]TAZ) is a derivative of the antiestrogen tamoxIFen. It covalently labels the Estrogen Receptor (ER), and perhaps other uncharacterized proteins.

ExcerptReferenceRelevance
"[3H]Tamoxifen Aziridine ([3H]TAZ) is a derivative of the antiestrogen tamoxifen that covalently labels the Estrogen Receptor (ER), and perhaps other uncharacterized proteins. "( Tamoxifen aziridine binding to cytosolic proteins from human breast specimens is negatively associated with estrogen receptors, progesterone receptors, pS2, and cathepsin-D.
Cabrera, JJ; Díaz-Chico, BN; Díaz-Chico, JC; Doreste, H; Morales, M; Navarro, D, 1998
)
2.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID69212Relative binding affinity (RBA) for Estrogen receptor compared to [3H]-estradiol1987Journal of medicinal chemistry, May, Volume: 30, Issue:5
Estrogenic affinity labels: synthesis, irreversible receptor binding, and bioactivity of aziridine-substituted hexestrol derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (53)

TimeframeStudies, This Drug (%)All Drugs %
pre-199020 (37.74)18.7374
1990's33 (62.26)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.55 (24.57)
Research Supply Index4.01 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.85%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other53 (98.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]